icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
pW7Drr02BDVAaMd4
Listen
